Inflation eases to 26-month low in Jan
India's headline inflation slowed to its lowest level in more than two years in January as food prices fell, increasing the pressure on the RBI to cut rates to battle the country's economic slowdown. Full Article
Reuters Showcase
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Glenmark product filing challenged by Abbott in U.S.
U.S.'s next top dog
Two thousand dogs vie to be named "Best in Show" at New York's Westminster Kennel Club Dog Show. Slideshow
MUMBAI |
MUMBAI (Reuters) - Glenmark Pharmaceuticals Ltd said on Thursday Abbott has filed a suit on December 7 in a U.S. court seeking to prevent it from proceeding with the commercialisation of certain products.
The products include trandolapril, verapamil and hydrochloride, for which Glenmark filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for marketing the generic version, it said in a statement.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters